Table 3.
Trait | SNP | Position * | Pval | Effect Alleles & | Study |
---|---|---|---|---|---|
Menstrual cycle length | rs11031006 | 30,204,981 | 1.1 × 10−38 | A > G | [20] |
Age at menarche | rs11031006 | 30,204,981 | 8.49 × 10−14 | A > G | [23] |
Age at menopause | rs11031006 | 30,204,981 | 8.5 × 10−14 | A > G | [31] |
Dizygotic twinning | rs11031006 | 30,204,981 | 1.25 × 10−10 | G > A | [44] |
FSH concentrations | rs11031005 rs11031006 |
30,204,809 30,204,981 |
1.74 × 10−8 2.3 × 10−10 |
T > C G > A |
[37] [44] |
LH concentrations | rs11031002 | 30,193,714 | 3.94 × 10−9 | T > A | [37] |
Endometriosis | rs74485684 | 30,220,740 | 2.00 × 10−8 | T > C | [27] |
Polycystic ovarian syndrome | rs11031005 | 30,204,809 | 8.66 × 10−13 | C > T | [45] |
Excessive, frequent and irregular menstruation | rs11031006 | 30,204,981 | 1.1 × 10−38 | A > G | [20] |
Uterine fibroids | rs11031006 | 30,204,981 | 5.7 × 10−15 | A > G | [54] |
Bilateral oophorectomy | rs11031006 | 30,204,981 | 1.1 × 10−38 | A > G | [20] |
The LD between each listed SNP has an r2 > 0.82, except for rs11031002 and rs74485684, which have an r2 of 0.69 (European population); * Position on chromosome 11 (GRCh38.p12); & Direction of effect (allele increasing trait value or disease risk > alternative allele).